Stress-induced hyperglycaemia and venous thromboembolism following total hip or total knee arthroplasty

Summary

Stress-induced hyperglycaemia is common during orthopaedic surgery. In addition, hyperglycaemia activates coagulation. The aim of the study was to assess whether stress-induced hyperglycaemia is associated with symptomatic or asymptomatic venous thromboembolism (VTE) following orthopaedic surgery. We performed post-hoc analyses in the four RECORD studies (REgulation of Coagulation in major Orthopaedic surgery reducing the Risk of Deep venous thrombosis and pulmonary embolism). Separate analyses were performed for patients undergoing elective total hip or knee replacement. Outcome measures were symptomatic VTE and “total VTE” (defined as the composite of symptomatic VTE, asymptomatic DVT assessed by per protocol venography and all cause mortality). Glucose levels were measured pre-op and 6 hours post-op, categorised into quartiles, based on the distribution in the respective cohorts. The influence of glucose, adjusted for body mass index, age, gender and diabetes mellitus on VTE was assessed by logistic regression analyses. A total of 12,383 patients were eligible for assessment of symptomatic VTE, and 8,512 patients were eligible for assessment of total VTE. Increased glucose levels after total hip replacement were associated with total VTE; adjusted odds ratio (OR) highest versus lowest quartile 1.9 (95% confidence interval [CI] 1.3 to 3.0). Furthermore, increase in glucose levels during total hip replacement was associated with total VTE (OR highest versus lowest quartile 1.8 (95%CI 1.2 to 2.8). This was not observed in patients undergoing total knee replacement, probably due to differences in the applied surgical procedures.

Keywords

Venous thromboembolism - deep venous thrombosis - pulmonary embolism - hyperglycaemia - arthroplasty

^* Both authors contributed equally to this manuscript.

• References

• 1 Naess IA, Christiansen SC, Romundstad P. et al. Incidence and mortality of venous thrombosis: a population-based study.. J Thromb Haemost 2007; 5: 692-699.
• 2 Lensing AW, Prandoni P, Prins MH. et al. Deep-vein thrombosis. Lancet 1999; 353: 479-485.
• 3 Spencer FA, Emery C, Lessard D. et al. The Worcester Venous Thromboembolism study: a population-based study of the clinical epidemiology of venous thromboembolism.. J Gen Intern Med 2006; 21: 722-727.
• 4 Stegenga ME, van der Crabben SN, Levi M. et al. Hyperglycemia stimulates coagulation, whereas hyperinsulinemia impairs fibrinolysis in healthy humans.. Diabetes 2006; 55: 1807-1812.
• 5 Stegenga ME, van der Crabben SN, Blumer RM. et al. Hyperglycemia enhances coagulation and reduces neutrophil degranulation, whereas hyperinsulinemia inhibits fibrinolysis during human endotoxemia.. Blood 2008; 112: 82-89.
• 6 Dungan KM, Braithwaite SS, Preiser JC.. Stress hyperglycaemia. Lancet 2009; 373: 1798-1807.
• 7 Hermanides J, Huijgen R, Henny CP. et al. Hip surgery sequentially induces stress hyperglycaemia and activates coagulation.. Neth J Med 2009; 67: 226-229.
• 8 Hermanides J, Cohn DM, Devries JH. et al. Venous thrombosis is associated with hyperglycemia at diagnosis: a case-control study.. J Thromb Haemost 2009; 7: 945-949.
• 9 Galster H, Kolb G, Kohsytorz A. et al. The pre-, peri-, and postsurgical activation of coagulation and the thromboembolic risk for different risk groups. Thromb Res 2000; 100: 381-388.
• 10 Warwick D, Friedman RJ, Agnelli G. et al. Insufficient duration of venous thromboembolism prophylaxis after total hip or knee replacement when compared with the time course of thromboembolic events: findings from the Global Orthopaedic Registry.. J Bone Joint Surg Br 2007; 89: 799-807.
• 11 Eriksson BI, Borris LC, Friedman RJ. et al. Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty.. N Engl J Med 2008; 358: 2765-2775.
• 12 Kakkar AK, Brenner B, Dahl OE. et al. Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial.. Lancet 2008; 372: 31-39.
• 13 Lassen MR, Ageno W, Borris LC. et al. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty.. N Engl J Med 2008; 358: 2776-2786.
• 14 Turpie AG, Lassen MR, Davidson BL. et al. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial.. Lancet 2009; 373: 1673-1680.
• 15 Rabinov K, Paulin S.. Roentgen diagnosis of venous thrombosis in the leg. Arch Surg 1972; 104: 134-144.
• 16 Mraovic B, Hipszer BR, Epstein RH. et al. Preadmission hyperglycemia is an independent risk factor for in-hospital symptomatic pulmonary embolism after major orthopedic surgery.. J Arthroplasty 2010; 25: 64-70.
• 17 Marchant Jr. MH, Viens NA, Cook C. et al. The impact of glycemic control and diabetes mellitus on perioperative outcomes after total joint arthroplasty.. J Bone Joint Surg Am 2009; 91: 1621-1629.
• 18 Carr ME.. Diabetes mellitus: a hypercoagulable state. J Diabetes Complications 2001; 15: 44-54.
• 19 Diagnosis and classification of diabetes mellitus.. Diabetes Care 2008; 31 (Suppl. 01) S55-S60.
• 20 Sharrock NE, Go G, Sculco TP. et al. Changes in circulatory indices of thrombosis and fibrinolysis during total knee arthroplasty performed under tourniquet. J Arthroplasty 1995; 10: 523-528.
• 21 Parmet JL, Horrow JC, Pharo G. et al. The incidence of venous emboli during extramedullary guided total knee arthroplasty. Anesth Analg 1995; 81: 757-762.
• 22 Parmet JL, Horrow JC, Berman AT. et al. The incidence of large venous emboli during total knee arthroplasty without pneumatic tourniquet use. Anesth Analg 1998; 87: 439-444.
• 23 Westman B, Weidenhielm L, Rooyackers O. et al. Knee replacement surgery as a human clinical model of the effects of ischaemia/reperfusion upon skeletal muscle.. Clin Sci 2007; 113: 313-318.
• 24 Carles M, Dellamonica J, Roux J. et al. Sevoflurane but not propofol increases interstitial glycolysis metabolites availability during tourniquet-induced ischaemia-reperfusion.. Br J Anaesth 2008; 100: 29-35.
• 25 Kehlet H, Brandt MR, Hansen AP. et al. Effect of epidural analgesia on metabolic profiles during and after surgery. Br J Surg 1979; 66: 543-546.
• 26 Lattermann R, Belohlavek G, Wittmann S. et al. The anticatabolic effect of neuraxial blockade after hip surgery.. Anesth Analg 2005; 101: 1202-1208.
• 27 Schricker T, Carvalho G, Meterissian S.. Epidural combined with propofol anesthesia does not suppress the hyperglycemic response to abdominal surgery. Can J Anaesth 2005; 52: 652.